VKTX.O (VKTX.O) News
Track canonical SquawkNews coverage tagged to VKTX.O, VKTX.O. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 3 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
BRIEF — Viking Therapeutics Prices Upsized $500 Million Offering Of Common Stock And Convertible Senior Notes
Sept 24 (Reuters) — Viking Therapeutics, Inc.: Viking Therapeutics Prices Upsized $500 Million Offering Of Common Stock And Convertible Senior Notes Viking Therapeutics, - Offering Size Increased To $275 Million Common S
EQUITY | Sep 24, 2026, 11:10 AM UTC
L
Viking Therapeutics prices USD 225 million convertible senior notes offering
Viking Therapeutics priced an upsized USD 225 million offering of 2.00% convertible senior notes due 2032. Settlement is scheduled for Sept. 25, subject to customary closing conditions. Underwriters hold a 30-day option
EQUITY | Sep 24, 2026, 11:06 AM UTC
L
BUZZ — Viking Therapeutics falls on $275 mln stock, $225 mln convertible deals
* Shares of Viking Therapeutics down 9.6% at $37.65 before the bell on Thurs after securing capital raise * VKTX sells ~7.9 mln shares at $35 for $275 mln gross proceeds; offering price represents 16% discount to stock's
EQUITY | Sep 24, 2026, 10:41 AM UTC